Paperpal Prime Logo

European Endocrinology : Impact Factor & More

eISSN: 1758-3780pISSN: 1758-3772

Key Metrics

CiteScore
4.4
SJR
Q4Endocrinology
SNIP
1.19
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on European Endocrinology

European Endocrinology Journal Specifications

Overview
Publisher Touch Medical Media

Planning to publish in European Endocrinology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Endocrinology

Cannulated prolactin test: Useful test to investigate patients with mild hyperprolactinemia?
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Knowledge, attitude and practice on continuous glucose monitoring and self-monitoring of blood glucose among healthcare professionals across India: A cross-sectional study
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Type 2 diabetes and the cardio–renal–metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Balancing clinical benefits and behavioral risks of obesity-focused management in youth-onset type 2 diabetes: A narrative review
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Efficacy and Safety of Oral Semaglutide in the Management of Diabetes and Obesity: A Comprehensive Meta-analysis of Real-world Evidence
  • 1 May 2026
  • touchREVIEWS in Endocrinology
Cannulated prolactin test: Useful test to investigate patients with mild hyperprolactinemia?
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Knowledge, attitude and practice on continuous glucose monitoring and self-monitoring of blood glucose among healthcare professionals across India: A cross-sectional study
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Type 2 diabetes and the cardio–renal–metabolic syndrome: The evolving roles of GLP-1 and dual GLP-1/GIP receptor agonists
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Balancing clinical benefits and behavioral risks of obesity-focused management in youth-onset type 2 diabetes: A narrative review
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Disease-modifying approach to cardiovascular–kidney–metabolic syndrome: The role of combining GLP-1RAs and SGLT-2is
  • 1 Oct 2026
  • touchREVIEWS in Endocrinology
Efficacy and Safety of Oral Semaglutide in the Management of Diabetes and Obesity: A Comprehensive Meta-analysis of Real-world Evidence
  • 1 May 2026
  • touchREVIEWS in Endocrinology

FAQs on European Endocrinology